Contraceptive Accelerator Network

Contraceptive Accelerator Network is small, mission-based pharmaceutical company ensuring that promising non-hormonal, reversible contraceptive options for those who produce sperm receive the support necessary for development as next generation birth control methods. CAN is a subsidiary of the non-profit Male Contraceptive Initiative (MCI), and works in parallel with it to identify appropriate products and programs and support them with the testing and evaluation processes required prior to IND-enabling studies and clinical trials. The company’s operations are streamlined and intentionally designed to maximize cost efficiency in all activities, taking advantage of the many drug discovery resources commercially available to increase our impact while reducing overhead costs and allowing for an expanded portfolio of projects as appropriate.